ketoconazole has been researched along with Sporothrix brasiliensis Infection in 46 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Itraconazole, a new orally absorbable azole derivative, was used for the treatment of 17 patients with cutaneous and lymphangitic sporotrichosis." | 9.06 | Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. ( Gómez, I; Gutiérrez, R; Restrepo, A; Robledo, J; Tabares, AM, 1986) |
"To describe the clinical presentation and outcomes of treatment with itraconazole in patients with sporotrichosis." | 7.68 | Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. ( Cloud, G; Dismukes, WE; Graybill, JR; Hostetler, JS; Kauffman, CA; Sharkey-Mathis, PK; Stevens, DA, 1993) |
" Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
"The effectiveness and safety of treatment with ketoconazole and itraconazole were compared in 773 sporotrichosis-infected cats over a four-year period (2002 to 2005)." | 5.14 | Response to azolic antifungal agents for treating feline sporotrichosis. ( Figueiredo, FB; Gremião, ID; Monteiro, PC; Passos, SR; Pereira, SA; Schubach, TM; Silva, JN; Teixeira, JL, 2010) |
"Itraconazole, a new orally absorbable azole derivative, was used for the treatment of 17 patients with cutaneous and lymphangitic sporotrichosis." | 5.06 | Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. ( Gómez, I; Gutiérrez, R; Restrepo, A; Robledo, J; Tabares, AM, 1986) |
"To describe the clinical presentation and outcomes of treatment with itraconazole in patients with sporotrichosis." | 3.68 | Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. ( Cloud, G; Dismukes, WE; Graybill, JR; Hostetler, JS; Kauffman, CA; Sharkey-Mathis, PK; Stevens, DA, 1993) |
" Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
"Four antifungal agents, amphotericin B, SDZ 89-485, itraconazole, and terbinafine, were tested for efficacy in a murine model of systemic sporotrichosis." | 3.67 | Efficacies of four antifungal agents in experimental murine sporotrichosis. ( Bennett, JE; Kan, VL, 1988) |
"The efficacy of ketoconazole was evaluated in forty-five patients with dermatophytoses, in twelve with candidosis, in two with fixed cutaneous sporotrichosis, in one with primary cutaneous cryptococcosis and in one with pulmonary aspergillosis." | 3.67 | Therapeutic experience with ketoconazole. ( Difonzo, EM; Palleschi, GM; Panconesi, E; Vannini, P, 1986) |
"We treated 29 patients with ketoconazole for systemic mycoses." | 3.66 | Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens. ( Craven, PC; Donovan, W; Graybill, JR; Matthew, EB, 1982) |
"The epidemic of sporotrichosis has been occurring for three decades in the province of Abancay in Peru." | 2.52 | Sporotrichosis: The Story of an Endemic Region in Peru over 28 Years (1985 to 2012). ( Ramírez Soto, MC, 2015) |
"Sporotrichosis is the disease caused by the dimorphic fungus Sporothrix schenkii." | 2.38 | Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. ( Fuhrer, J; Heller, HM, 1991) |
"Pulmonary sporotrichosis is most commonly found in males with a history of alcohol abuse who are between the ages of 30 and 60." | 2.37 | Pulmonary sporotrichosis: review of treatment and outcome. ( Opal, SM; Pluss, JL, 1986) |
"The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
"Canine sporotrichosis is a poorly reported disease, and the majority of cases are from Rio de Janeiro, Brazil." | 1.62 | Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil. ( Almeida-Paes, R; Boechat, JS; de Oliveira, MME; de Sá Machado, AC; Gremião, IDF; Pereira, SA; Viana, PG; Zancopé-Oliveira, RM, 2021) |
"Sporotrichosis is an emerging chronic, granulomatous, subcutaneous, mycotic infection caused by Sporothrix species." | 1.48 | In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: Special focus on CYP51. ( Abdalla, SMH; Bamal, HD; Gront, D; Kgosiemang, IKR; Manume, NA; Mashele, SS; Matowane, RG; Syed, K; Van Wyk, M; Wieteska, L, 2018) |
"Feline sporotrichosis is common in Malaysia." | 1.46 | Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats. ( Chen, C; Han, HS; Kano, R; Noli, C, 2017) |
"Although blastomycosis is endemic in North America, only 4 cases have been identified in Natal during the last 25 years, and all presented with atypical clinical features." | 1.28 | Tropical mycoses. ( Bayles, MA, 1992) |
"Although blastomycosis is endemic in North America, only four cases have been identified in Natal during the last 25 years and all presented with atypical clinical features." | 1.28 | [Tropical mycoses]. ( Bayles, MA, 1991) |
"Sporotrichosis is rarely included in the differential diagnosis of rosacea." | 1.27 | Rosacea-like sporotrichosis. ( Day, TW; Gibson, GH; Guin, JD, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (45.65) | 18.7374 |
1990's | 14 (30.43) | 18.2507 |
2000's | 3 (6.52) | 29.6817 |
2010's | 6 (13.04) | 24.3611 |
2020's | 2 (4.35) | 2.80 |
Authors | Studies |
---|---|
Alvarado-Ramírez, E | 1 |
Torres-Rodríguez, JM | 1 |
Marimon, R | 1 |
Serena, C | 1 |
Gené, J | 1 |
Cano, J | 1 |
Guarro, J | 1 |
Indoung, S | 1 |
Chanchayanon, B | 1 |
Chaisut, M | 1 |
Buapeth, KO | 1 |
Morteh, R | 1 |
Jantrakajorn, S | 1 |
Boechat, JS | 1 |
Pereira, SA | 2 |
de Sá Machado, AC | 1 |
Viana, PG | 1 |
Almeida-Paes, R | 1 |
Zancopé-Oliveira, RM | 1 |
Gremião, IDF | 1 |
de Oliveira, MME | 1 |
Matowane, RG | 1 |
Wieteska, L | 1 |
Bamal, HD | 1 |
Kgosiemang, IKR | 1 |
Van Wyk, M | 1 |
Manume, NA | 1 |
Abdalla, SMH | 1 |
Mashele, SS | 1 |
Gront, D | 1 |
Syed, K | 1 |
Ramírez Soto, MC | 1 |
Han, HS | 1 |
Kano, R | 1 |
Chen, C | 1 |
Noli, C | 1 |
Passos, SR | 1 |
Silva, JN | 1 |
Gremião, ID | 1 |
Figueiredo, FB | 1 |
Teixeira, JL | 1 |
Monteiro, PC | 1 |
Schubach, TM | 2 |
Landell, MF | 1 |
Stopiglia, CD | 1 |
Billodre, RG | 1 |
Heidrich, D | 1 |
Sorrentino, JM | 1 |
Vainstein, MH | 1 |
Scroferneker, ML | 1 |
Valente, P | 1 |
dos Santos, IB | 1 |
Quintella, LP | 1 |
de Miranda, LH | 1 |
de Sousa Trotte, MN | 1 |
Tortelly, R | 1 |
Carod, JF | 1 |
Ramarozatovo, L | 1 |
Randrianasolo, P | 1 |
Ratsima, E | 1 |
Randrianirina, F | 1 |
Rapelanoro, FR | 1 |
Day, TW | 1 |
Gibson, GH | 1 |
Guin, JD | 1 |
Samorodin, CS | 1 |
Sina, B | 1 |
Reshad, H | 1 |
Pegum, JS | 1 |
Keir, MI | 1 |
Hay, RJ | 1 |
Graybill, JR | 2 |
Craven, PC | 1 |
Donovan, W | 1 |
Matthew, EB | 1 |
Martins, JE | 1 |
de Mendonça, PR | 1 |
Cucé, LC | 1 |
Horsburgh, CR | 1 |
Cannady, PB | 1 |
Kirkpatrick, CH | 1 |
Morgan, MA | 1 |
Cockerill, FR | 1 |
Cortese, DA | 1 |
Roberts, GD | 1 |
Deutsch, PH | 1 |
Quintiliani, R | 1 |
Naqvi, SH | 1 |
Becherer, P | 1 |
Gudipati, S | 1 |
Breeling, JL | 1 |
Weinstein, L | 1 |
Sharkey-Mathis, PK | 1 |
Kauffman, CA | 2 |
Stevens, DA | 2 |
Hostetler, JS | 1 |
Cloud, G | 1 |
Dismukes, WE | 2 |
Dupont, B | 1 |
Bayles, MA | 2 |
Van Cutsem, J | 1 |
Cullen, SI | 1 |
Mauceri, AA | 1 |
Warner, N | 1 |
Heller, HM | 1 |
Fuhrer, J | 1 |
Puiatti, P | 1 |
Alberico, G | 1 |
Cotilli, G | 1 |
Salvai, M | 1 |
Goitre, M | 1 |
Kramer, MR | 1 |
Marshall, SE | 1 |
Denning, DW | 1 |
Keogh, AM | 1 |
Tucker, RM | 1 |
Galgiani, JN | 1 |
Lewiston, NJ | 1 |
Theodore, J | 1 |
Viviani, MA | 2 |
Tortorano, AM | 2 |
Pagano, A | 1 |
Vigevani, GM | 1 |
Gubertini, G | 1 |
Cristina, S | 1 |
Assaisso, ML | 1 |
Suter, F | 1 |
Farina, C | 1 |
Minetti, B | 1 |
Cuadros, RG | 1 |
Vidotto, V | 1 |
Bruatto, M | 1 |
Baker, JH | 1 |
Goodpasture, HC | 1 |
Kuhns, HR | 1 |
Rinaldi, MG | 1 |
Fields, CL | 1 |
Ossorio, MA | 1 |
Roy, TM | 1 |
Kan, VL | 1 |
Bennett, JE | 1 |
Restrepo, A | 1 |
Robledo, J | 1 |
Gómez, I | 1 |
Tabares, AM | 1 |
Gutiérrez, R | 1 |
Schaude, M | 1 |
Meingassner, JG | 1 |
Woenstenborghs, R | 1 |
Cauwenbergh, G | 1 |
Terpenning, MS | 1 |
Pluss, JL | 1 |
Opal, SM | 1 |
Meyer, RD | 1 |
Dunstan, RW | 1 |
Reimann, KA | 1 |
Langham, RF | 1 |
Bojanovsky, A | 1 |
Weiss, J | 1 |
Difonzo, EM | 1 |
Palleschi, GM | 1 |
Vannini, P | 1 |
Panconesi, E | 1 |
Shadomy, S | 1 |
Espinel-Ingroff, A | 1 |
Tartaglione, TA | 1 |
7 reviews available for ketoconazole and Sporothrix brasiliensis Infection
Article | Year |
---|---|
Sporotrichosis: The Story of an Endemic Region in Peru over 28 Years (1985 to 2012).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Endemic Dise | 2015 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bla | 1998 |
Disseminated sporotrichosis in patients with AIDS: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Biopsy; Bisexuality; HIV-1; Humans; Itraconazole; Ketoconazole; | 1991 |
Deep fungal infections in the elderly.
Topics: Age Factors; Aged; Amphotericin B; Blastomycosis; Coccidioidomycosis; Histoplasmosis; Humans; Ketoco | 1988 |
Pulmonary sporotrichosis: review of treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Ketoconazole; | 1986 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
2 trials available for ketoconazole and Sporothrix brasiliensis Infection
Article | Year |
---|---|
Response to azolic antifungal agents for treating feline sporotrichosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Appetite; Cat Diseases; Cats; Diarrhea; Female; It | 2010 |
Itraconazole therapy in lymphangitic and cutaneous sporotrichosis.
Topics: Adolescent; Adult; Animals; Antifungal Agents; Child; Clinical Trials as Topic; Dermatomycoses; Fema | 1986 |
37 other studies available for ketoconazole and Sporothrix brasiliensis Infection
Article | Year |
---|---|
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazo | 2007 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Sp | 2008 |
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Topics: Amphotericin B; Animals; Antifungal Agents; Calmodulin; Cat Diseases; Cats; Fluconazole; Itraconazol | 2022 |
Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Itraconazole; Ketoconazole; | 2021 |
In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: Special focus on CYP51.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Catalytic Domain; Crystallography, X-Ray; Cytochrom | 2018 |
Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; In Vitro Techniques; Itraconazole; K | 2017 |
Evaluation of the origin of a sample of Sporothrix schenckii that caused contamination of a researcher in Southern Brazil.
Topics: Brazil; Fluconazole; Humans; Ketoconazole; Laboratories; Male; Microbial Sensitivity Tests; Potassiu | 2011 |
Atypical feline sporotrichosis resembling vaccine-induced sarcoma: clinical and histopathological aspects.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Female; Ketoconazole; Sarcoma; Soft Tissue Neoplasms | 2013 |
[Cutaneous sporotricosis in a Malagasy patient].
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Itraconazole; Ketoconazole; Mad | 2007 |
Rosacea-like sporotrichosis.
Topics: Diagnosis, Differential; Humans; Ketoconazole; Male; Middle Aged; Potassium Iodide; Rosacea; Sporotr | 1984 |
Ketoconazole-treated sporotrichosis in a veterinarian.
Topics: Animals; Cats; Humans; Ketoconazole; Male; Middle Aged; Occupational Diseases; Sporotrichosis; Veter | 1984 |
Cutaneous lymphatic sporotrichosis treated with ketoconazole--report of an infection acquired in the United Kingdom.
Topics: Aged; Dermatomycoses; Humans; Ketoconazole; Male; Sporotrichosis | 1984 |
Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens.
Topics: Adolescent; Adult; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Adm | 1982 |
[Treatment of sporotrichosis with ketoconazole].
Topics: Adult; Female; Humans; Imidazoles; Ketoconazole; Piperazines; Sporotrichosis | 1982 |
Treatment of fungal infections in the bones and joints with ketoconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Bone Diseases; Child; Coccidioidomycosis; Humans; Imidazole | 1983 |
Disseminated sporotrichosis with Sporothrix schenckii fungemia.
Topics: Amphotericin B; Female; Humans; Ketoconazole; Middle Aged; Sepsis; Sporothrix; Sporotrichosis | 1984 |
Ketoconazole treatment of a family with zoonotic sporotrichosis.
Topics: Adult; Animals; Animals, Domestic; Cats; Child; Female; Humans; Ketoconazole; Male; Sporotrichosis; | 1993 |
Pulmonary sporotrichosis treated with itraconazole.
Topics: Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1993 |
Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Successful treatment of disseminated cutaneous sporotrichosis with ketoconazole.
Topics: Aged; Dermatomycoses; Humans; Ketoconazole; Male; Sporotrichosis | 1992 |
[Tropical mycoses].
Topics: Antifungal Agents; Blastomycosis; Chromoblastomycosis; Clinical Trials as Topic; Female; Histoplasmo | 1991 |
Sporotrichoid infection. Two cases.
Topics: Aged; Biopsy; Diagnosis, Differential; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1990 |
Cyclosporine and itraconazole interaction in heart and lung transplant recipients.
Topics: Aspergillosis; Coccidiosis; Cyclosporins; Drug Interactions; Heart Transplantation; Heart-Lung Trans | 1990 |
European experience with itraconazole in systemic mycoses.
Topics: Antifungal Agents; Aspergillosis; Child; Cryptococcosis; Drug Administration Schedule; Humans; Itrac | 1990 |
Sporotrichosis in the metropolitan area of Cusco, Peru, and in its region.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dermatomycoses; Female; Humans; Ketoconazole; Male | 1990 |
Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; M | 1989 |
Empyema associated with pulmonary sporotrichosis.
Topics: Empyema; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Pleural Effusion; Potassium | 1989 |
Efficacies of four antifungal agents in experimental murine sporotrichosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Evaluation, Preclinical; Itraconazole; Ketoconazole | 1988 |
A diffusion chamber technique for testing of antifungal drugs against Sporothrix schenckii in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Female; Itraconazole; Ketoconazo | 1986 |
Experience with itraconazole in deep mycoses in northern Italy.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Itraconazole; Ketoconazole; Sporotrichosis | 1987 |
Feline sporotrichosis.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Female; Humans; Ketoconazole; Male; Potassium Iodide; S | 1986 |
[Lymphangitic sporotrichosis].
Topics: Biopsy; Female; Humans; Ketoconazole; Lymphangitis; Middle Aged; Skin; Sporotrichosis | 1987 |
Therapeutic experience with ketoconazole.
Topics: Candidiasis, Vulvovaginal; Dermatomycoses; Female; Humans; Ketoconazole; Sporotrichosis; Tinea | 1986 |
Treatment of systemic mycoses with ketoconazole: studies of ketoconazole serum levels.
Topics: Blastomycosis; Child, Preschool; Coccidioidomycosis; Cryptococcosis; Histoplasmosis; Humans; Ketocon | 1986 |